Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating the addition of tirapazamine to standard chemotherapy for stage IIIB/IV non-small cell lung cancer has been compl…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]
Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysp…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating trastuzumab in combination with chemotherapy for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating a vaccine therapy in patients with stage III non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Phase I Study of Vorinostat and Sorafenib in Advanced Cancer [Phase 1]
Phase I study update of the combination of vorinostat and sorafenib in patients with advanced cancer, with completed status. Diseases includ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery [NA]
This clinical trial update reports the completion of a study evaluating vaccine therapy combined with chemotherapy and radiation therapy for…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating 10-Propargyl-10-Deazaaminopterin for stage IIIB/IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating a cancer vaccine therapy in combination with sargramostim for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC [Phase 2]
A Phase 2 study assessing low-dose chemotherapy plus sorafenib as initial therapy for advanced non-squamous non-small cell lung cancer was t…
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating a combination chemotherapy regimen for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab [Phase 2]
This completed Phase II randomized study in inoperable non-squamous non-small cell lung cancer compared Bevacizumab plus Erlotinib versus Ge…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene [Phase 3]
A Phase 3 trial evaluated crizotinib (PF-02341066) versus standard of care in advanced ALK-positive non-small cell lung cancer; the study is…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer [Phase 2]
This is a completed Phase 2 trial update evaluating Erlotinib in combination with Celecoxib for patients with Stage IIIB or Stage IV recurre…
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection [Phase 2]
A Phase 2 clinical trial evaluating erlotinib in patients with stage I-IIIA non-small cell lung cancer undergoing surgical resection has bee…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy [Phase 2]
The document reports the completed Phase 2 trial of Epothilone D in patients with stage IIIB or IV non-small cell lung cancer that has progr…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with docetaxel plus cetuximab or docetaxel plus bortezomib in patients with Stage IIIB or Stage…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating tipifarnib combined with gemcitabine and cisplatin in stage IIIB or stage IV non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating the combination of suramin, paclitaxel, and carboplatin in patients with stage IIIB or stage IV non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining interleukin-12, paclitaxel, and trastuzumab in patients with vario…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating suramin with docetaxel or gemcitabine in patients with platinum-…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating chemotherapy, radiation therapy, and surgery for stage IIIA non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial results evaluate erlotinib as neoadjuvant therapy in patients with stage IIIA, N2-positive non-small cell lung cancer, reporti…
-
CLINICAL_TRIALS trial_result · 2013-05-21Clinical Trial Update: Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer [NA]
A completed clinical trial evaluated celecoxib for treating patients with stage I to IIIA non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial of allogeneic cellular vaccine 1650-G for non-small cell lung cancer completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial results evaluating 3-AP (Triapine) in combination with Gemcitabine as second-line therapy for stage III or IV recurrent non-sm…